Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control

Journal of Experimental Medicine

Volumn 198, Issue 7, 2003, Pages 1023-1034

  Mullins, David W ^a,b   Sheasley, Stacey L ^a,b   Ream, Rebecca M ^a,b   Bullock, Timothy N J ^a,b   Fu, Yang Xin ^c   Engelhard, Victor H ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Active immunotherapy; Regional immunity; T cell homing; T cell memory; Vaccination

Indexed keywords

CHEMOKINE RECEPTOR CCR7;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CANCER CONTROL; CELL COMPARTMENTALIZATION; DENDRITIC CELL; EFFECTOR CELL; IMMUNIZATION; LYMPHOID TISSUE; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION; TUMOR GROWTH; VACCINATION;

ANIMALS; DENDRITIC CELLS; IMMUNOLOGIC MEMORY; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LUNG NEOPLASMS; LYMPH NODES; MELANOMA, EXPERIMENTAL; MICE; NEOPLASMS, EXPERIMENTAL; SKIN NEOPLASMS; T-LYMPHOCYTES; VACCINATION;

EID: 0141993954     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021348     Document Type: Article

References (36)

1. + cytolytic T lymphocytes by dendritic cells. Adv. Exp. Med. Biol. 378:375-379.
2. Mullins, D.W., T.N. Bullock, T.A. Colella, V.V. Robila, and V.H. Engelhard. 2001. Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice. J. Immunol. 167:4853-4860.
3. Steinman, R.M., and M. Dhodapkar. 2001. Active immunization against cancer with dendritic cells: the near future. Int. J. Cancer. 94:459-473.
4. Steinman, R.M., K. Inaba, S. Turley, P. Pierre, and I. Mellman. 1999. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum. Immunol. 60:562-567.
5. Mellman, I., and R.M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell. 106:255-258.
6. Cyster, J.G. 1999. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J. Exp. Med. 189:447-450.
7. Sallusto, F., and A. Lanzavecchia. 2000. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 177:134-140.
8. Campbell, J.J., and E.C. Butcher. 2000. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 12:336-341.
9. Rott, L.S., M.J. Briskin, D.P. Andrew, E.L. Berg, and E.C. Butcher. 1996. A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with β7 integrins and memory differentiation. J. Immunol. 156:3727-3736.
10. Gunzer, M., and S. Grabbe. 2001. Dendritic cells in cancer immunotherapy. Crit. Rev. Immunol. 21:133-145.
11. Eggert, A.A., M.W. Schreurs, O.C. Boerman, W.J. Oyen, A.J. de Boer, C.J. Punt, C.G. Figdor, and G.J. Adema. 1999. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res. 59:3340-3345.
12. Okada, N., M. Tsujino, Y. Hagiwara, A. Tada, Y. Tamura, K. Mori, T. Saito, S. Nakagawa, T. Mayumi, T. Fujita, et al. 2001. Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens. Br. J. Cancer. 84:1564-1570.
13. Fong, L., D. Brockstedt, C. Benike, L. Wu, and E.G. Engleman. 2001. Dendritic cells injected via different routes induce immunity in cancer patients. J. Immunol. 166:4254-4259.
14. Serody, J.S., E.J. Collins, R.M. Tisch, J.J. Kuhns, and J.A. Frelinger. 2000. T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery. J. Immunol. 164:4961-4967.
15. Kaplan, J.M., Q. Yu, S.T. Piraino, S.F. Pennington, S. Shankara, L.A. Woodworth, and B.L. Roberts. 1999. Induction of anti-tumor immunity using dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens. J. Immunol. 163:699-707.
16. Boczkowski, D., S.K. Nair, J.H. Nam, H.K. Lyerly, and E. Gilboa. 2000. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res. 60:1028-1034.
17. Russo, V., S. Tanzarella, P. Dalerba, D. Rigatti, P. Rovere, A. Villa, C. Bordignon, and C. Traversari. 2000. Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response. Proc. Natl. Acad. Sci. USA. 97:2185-2190.
18. Kotera, Y., K. Shimizu, and J.J. Mule. 2001. Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. Cancer Res. 61:8105-8109.
19. Lambert, L.A., G.R. Gibson, M. Maloney, B. Durell, R.J. Noelle, and R.J. Barth, Jr. 2001. Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity. Cancer Res. 61:641-646.
20. + T cells for melanoma immunotherapy in human MHC class I-transgenic mice. J. Immunol. 167:5824-5831.
21. Lappin, M.B., J.M. Weiss, V. Delattre, B. Mai, H. Dittmar, C. Maier, K. Manke, S. Grabbe, S. Martin, and J.C. Simon. 1999. Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection. Immunol. 98:181-188.
22. Colella, T.A., T.N.J. Bullock, L.B. Russell, D.W. Mullins, W. Overwijk, C.J. Luckey, R.A. Pierce, N.P. Restifo, and V.H. Engelhard. 2000. Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy. J. Exp. Med. 191:1221-1231.
23. Newberg, M.H., J.P. Ridge, D.R. Vining, R.D. Salter, and V.H. Engelhard. 1992. Species specificity in the interaction of CD8 with the α3 domain of MHC class I molecules. J. Immunol. 149:136-142.
24. Rinchik, E.M., J.P. Stoye, W.N. Frankel, J. Coffin, B.S. Kwon, and L.B. Russell. 1993. Molecular analysis of viable spontaneous and radiation-induced albino (c)-locus mutations in the mouse. Mut. Res. 286:199-207.
25. Roberts, C.W., J.R. Shutter, and S.J. Korsmeyer. 1994. Hox11 controls the genesis of the spleen. Nature. 368:747-749.
26. Bullock, T.N.J., T.A. Colella, and V.H. Engelhard. 2000. The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice. J. Immunol. 164:2354-2361.
27. Rennert, P.D., P.S. Hochman, R.A. Flavell, D.D. Chaplin, S. Jayaraman, J.L. Browning, and Y.X. Fu. 2001. Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-α-deficient mice. J. Exp. Med. 193:1227-1238.
28. Marzo, A.L., R.A. Lake, D. Lo, L. Sherman, A. McWilliam, D. Nelson, B.W. Robinson, and B. Scott. 1999. Tumor antigens are constitutively presented in the draining lymph nodes. J. Immunol. 162:5838-5845.
29. Tang, M.L., D.A. Steeber, X.Q. Zhang, and T.F. Tedder. 1998. Intrinsic differences in L-selectin expression levels affect T and B lymphocyte subset-specific recirculation pathways. J. Immunol. 160:5113-5121.
30. Zitvogel, L., J.I. Mayordomo, T. Tjandrawan, A.B. DeLeo, M.R. Clarke, M.T. Lotze, and W.J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183:87-97.
31. Butcher, E.C., M. Williams, K. Youngman, L. Rott, and M. Briskin. 1999. Lymphocyte trafficking and regional immunity. Adv. Immunol. 72:209-253.
32. Nolte, M.A., A. Hamann, G. Kraal, and R.E. Mebius. 2002. The strict regulation of lymphocyte migration to splenic white pulp does not involve common homing receptors. Immunol. 106:299-307.
33. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:708-712.
34. + T cells. J. Exp. Med. 194:953-966.
35. Hemmi, H., M. Yoshino, H, Yamazaki, M. Naito, T. Iyoda, Y. Omatsu, S. Shimoyama, J.J. Letterio, T. Nakabayashi, H. Tagaya, et al. 2001. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells. Int. Immunol. 13:695-704.
36. Gunzer, M., S. Janich, G. Varga, and S. Grabbe. 2001. Dendritic cells and tumor immunity. Semin. Immunol. 13:291-302.